The Impact of Sinopharm COVID-19 Vaccination on Male Fertility

NCT04946565 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-07-07

No results posted yet for this study

Summary

The investigators shall study the effect of Sinopharm vaccination on semen parameters and serum testosterone

Conditions

  • Male Infertility
  • Hypogonadism, Male

Interventions

DIAGNOSTIC_TEST

Semen analysis

Semen analysis according to WHO laboratory manual for the examination and processing of human semen, Fifth edition

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohamed Tarek H Anis, M.D. · Cairo University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-03
Primary Completion
2022-06-30
Completion
2022-08-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04946565 on ClinicalTrials.gov